Calvo A - Search Results

1

Cytology Smears in the Era of Molecular Biomarkers in Non-Small Cell Lung Cancer: Doing More With Less.

Lozano MD, Echeveste JI, Abengozar M, Mejías LD, Idoate MA, Calvo A, de Andrea CE. Lozano MD, et al. Among authors: calvo a. Arch Pathol Lab Med. 2018 Mar;142(3):291-298. doi: 10.5858/arpa.2017-0208-RA. Arch Pathol Lab Med. 2018. PMID: 29494220 Free article. Review.

2

Identification of importin 8 (IPO8) as the most accurate reference gene for the clinicopathological analysis of lung specimens.

Nguewa PA, Agorreta J, Blanco D, Lozano MD, Gomez-Roman J, Sanchez BA, Valles I, Pajares MJ, Pio R, Rodriguez MJ, Montuenga LM, Calvo A. Nguewa PA, et al. Among authors: calvo a. BMC Mol Biol. 2008 Nov 17;9:103. doi: 10.1186/1471-2199-9-103. BMC Mol Biol. 2008. PMID: 19014639 Free PMC article.

3

Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model.

Diaz R, Nguewa PA, Parrondo R, Perez-Stable C, Manrique I, Redrado M, Catena R, Collantes M, Peñuelas I, Díaz-González JA, Calvo A. Diaz R, et al. Among authors: calvo a. BMC Cancer. 2010 May 11;10:188. doi: 10.1186/1471-2407-10-188. BMC Cancer. 2010. PMID: 20459769 Free PMC article.

4

Tyrosine kinase inhibitors with antiangiogenic properties for the treatment of non-small cell lung cancer.

Nguewa PA, Calvo A, Pullamsetti SS, Banat GA, Grimminger F, Savai R. Nguewa PA, et al. Among authors: calvo a. Expert Opin Investig Drugs. 2011 Jan;20(1):61-74. doi: 10.1517/13543784.2011.541153. Epub 2010 Dec 11. Expert Opin Investig Drugs. 2011. PMID: 21142806 Review.

5

Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance.

Ponz-Sarvisé M, Nguewa PA, Pajares MJ, Agorreta J, Lozano MD, Redrado M, Pio R, Behrens C, Wistuba II, García-Franco CE, García-Foncillas J, Montuenga LM, Calvo A, Gil-Bazo I. Ponz-Sarvisé M, et al. Among authors: calvo a. Clin Cancer Res. 2011 Jun 15;17(12):4155-66. doi: 10.1158/1078-0432.CCR-10-3381. Epub 2011 May 3. Clin Cancer Res. 2011. PMID: 21540238

6

Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology.

Larzabal L, Nguewa PA, Pio R, Blanco D, Sanchez B, Rodríguez MJ, Pajares MJ, Catena R, Montuenga LM, Calvo A. Larzabal L, et al. Among authors: calvo a. Br J Cancer. 2011 Nov 8;105(10):1608-14. doi: 10.1038/bjc.2011.432. Br J Cancer. 2011. PMID: 22067904 Free PMC article.

7

Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy.

Castañon E, Bosch-Barrera J, López I, Collado V, Moreno M, López-Picazo JM, Arbea L, Lozano MD, Calvo A, Gil-Bazo I. Castañon E, et al. Among authors: calvo a. J Transl Med. 2013 Jan 11;11:13. doi: 10.1186/1479-5876-11-13. J Transl Med. 2013. PMID: 23311395 Free PMC article.

8

Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma.

Prior C, Perez-Gracia JL, Garcia-Donas J, Rodriguez-Antona C, Guruceaga E, Esteban E, Suarez C, Castellano D, del Alba AG, Lozano MD, Carles J, Climent MA, Arranz JA, Gallardo E, Puente J, Bellmunt J, Gurpide A, Lopez-Picazo JM, Hernandez AG, Mellado B, Martínez E, Moreno F, Font A, Calvo A. Prior C, et al. Among authors: calvo a. PLoS One. 2014 Jan 24;9(1):e86263. doi: 10.1371/journal.pone.0086263. eCollection 2014. PLoS One. 2014. PMID: 24475095 Free PMC article.

9

TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.

de Aberasturi AL, Redrado M, Villalba M, Larzabal L, Pajares MJ, Garcia J, Evans SR, Garcia-Ros D, Bodegas ME, Lopez L, Montuenga L, Calvo A. de Aberasturi AL, et al. Among authors: calvo a. Cancer Lett. 2016 Jan 28;370(2):165-76. doi: 10.1016/j.canlet.2015.10.012. Epub 2015 Nov 4. Cancer Lett. 2016. PMID: 26546046

10

Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients.

Villalba M, Diaz-Lagares A, Redrado M, de Aberasturi AL, Segura V, Bodegas ME, Pajares MJ, Pio R, Freire J, Gomez-Roman J, Montuenga LM, Esteller M, Sandoval J, Calvo A. Villalba M, et al. Among authors: calvo a. Oncotarget. 2016 Apr 19;7(16):22752-69. doi: 10.18632/oncotarget.8045. Oncotarget. 2016. PMID: 26989022 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,091 results

Search Page